Search

Author/Creator Popov, Jesse

2. Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy. Issue 1 (2nd January 2023)

Authors:
Tyryshkin, Kathrin; Moore, Alison; Good, David; Popov, Jesse; Crocker, Susan; Rauh, Michael J.; Baetz, Tara; LeBrun, David P.
Journal:
Leukemia & lymphoma
Issue:
Volume 64:Issue 1(2023)
Page Start:
119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Step down to 6 months of prophylactic‐dose low molecular weight heparin after initial full‐dose anticoagulation for the treatment of cancer‐associated thrombosis (STEP‐CAT): A pilot study. (9th June 2022)

Authors:
Popov, Jesse; Coelho, Suellen; Carrier, Marc; Sperlich, Catherine; Solymoss, Susan; Routhier, Nathalie; Shivakumar, Sudeep; Aibibula, Wusiman; Kahn, Susan R.; Tagalakis, Vicky
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 20:Number 8(2022)
Page Start:
1868
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗